Archives

Decrease seen in mean monthly headache days and reduction in Migraine Disability Assessment scores

Rate of combined clinically significant or severe hypoglycemia significantly lower with efsitora versus glargine

Sensitivity and specificity for CT perfusion and CT angiography as ancillary test for death by neurologic criteria did not meet prespecified validation threshold in recent study

All three doses of orforglipron superior to placebo with respect to primary end point of change in HbA1c from baseline to week 40

Greater weight loss and more diabetes remission seen among adult women with overweight, obesity and T2D

Greater improvement in scores seen for patients with higher postoperative weight loss

Mild OSA present in 25 percent of female collegiate athletes in study

Increased rates of readmission, unplanned intervention, emergency department visits seen for Black versus White patients

Sustained reduction seen in body weight versus placebo for adults aged 18 to 75 with overweight or obesity, without diabetes

Lower risks for anxiety disorders, substance use disorders, cognitive deficits seen for those undergoing metabolic and bariatric surgery